Imugene (Australia) Market Value
| IMU Stock | 0.04 0 2.78% |
| Symbol | Imugene |
Imugene 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Imugene's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Imugene.
| 12/17/2024 |
| 03/17/2025 |
If you would invest 0.00 in Imugene on December 17, 2024 and sell it all today you would earn a total of 0.00 from holding Imugene or generate 0.0% return on investment in Imugene over 90 days. Imugene is related to or competes with Ras Technology, Aristocrat Leisure, BSP Financial, Finexia Financial, Medibank Private, and Viva Leisure. Imugene is entity of Australia. It is traded as Stock on AU exchange. More
Imugene Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Imugene's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Imugene upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.71 | |||
| Information Ratio | 0.0241 | |||
| Maximum Drawdown | 21.64 | |||
| Value At Risk | (5.13) | |||
| Potential Upside | 7.89 |
Imugene Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Imugene's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Imugene's standard deviation. In reality, there are many statistical measures that can use Imugene historical prices to predict the future Imugene's volatility.| Risk Adjusted Performance | 0.008 | |||
| Jensen Alpha | (0.03) | |||
| Total Risk Alpha | 0.5088 | |||
| Sortino Ratio | 0.0269 | |||
| Treynor Ratio | 0.0613 |
Imugene Backtested Returns
Currently, Imugene is out of control. Imugene holds Efficiency (Sharpe) Ratio of close to zero, which attests that the entity had a close to zero % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Imugene, which you can use to evaluate the volatility of the firm. Please check out Imugene's Market Risk Adjusted Performance of 0.0713, risk adjusted performance of 0.008, and Downside Deviation of 3.71 to validate if the risk estimate we provide is consistent with the expected return of 0.0363%. The company retains a Market Volatility (i.e., Beta) of -0.15, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Imugene are expected to decrease at a much lower rate. During the bear market, Imugene is likely to outperform the market. Imugene right now retains a risk of 4.11%. Please check out Imugene sortino ratio, maximum drawdown, potential upside, as well as the relationship between the treynor ratio and value at risk , to decide if Imugene will be following its current trending patterns.
Auto-correlation | 0.55 |
Modest predictability
Imugene has modest predictability. Overlapping area represents the amount of predictability between Imugene time series from 17th of December 2024 to 31st of January 2025 and 31st of January 2025 to 17th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Imugene price movement. The serial correlation of 0.55 indicates that about 55.0% of current Imugene price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.55 | |
| Spearman Rank Test | -0.06 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Imugene lagged returns against current returns
Autocorrelation, which is Imugene stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Imugene's stock expected returns. We can calculate the autocorrelation of Imugene returns to help us make a trade decision. For example, suppose you find that Imugene has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Imugene regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Imugene stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Imugene stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Imugene stock over time.
Current vs Lagged Prices |
| Timeline |
Imugene Lagged Returns
When evaluating Imugene's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Imugene stock have on its future price. Imugene autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Imugene autocorrelation shows the relationship between Imugene stock current value and its past values and can show if there is a momentum factor associated with investing in Imugene.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Imugene Stock Analysis
When running Imugene's price analysis, check to measure Imugene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Imugene is operating at the current time. Most of Imugene's value examination focuses on studying past and present price action to predict the probability of Imugene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Imugene's price. Additionally, you may evaluate how the addition of Imugene to your portfolios can decrease your overall portfolio volatility.